{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:48:14Z","timestamp":1751215694520,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ctro.2023.100722","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:20:48Z","timestamp":1703982048000},"page":"100722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Wee Loon","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Allan Hupman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Ruschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0117-6839","authenticated-orcid":false,"given":"Jay","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6851-0857","authenticated-orcid":false,"given":"Stanley","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Vesprini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4883-1781","authenticated-orcid":false,"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ctro.2023.100722_b0005","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","article-title":"Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy","volume":"23","author":"Martin","year":"2022","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100722_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2021.06.037","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: a combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"journal-title":"Int J Radiat Oncol Biol Phys","year":"2023","author":"Lui","key":"10.1016\/j.ctro.2023.100722_b0015"},{"issue":"4","key":"10.1016\/j.ctro.2023.100722_b0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2020.06.002","article-title":"Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial","volume":"108","author":"Jaccard","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2023.100722_b0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2019.08.007","article-title":"A Prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results","volume":"105","author":"Bruynzeel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100722_b0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fonc.2015.00194","article-title":"Urethrogram-directed stereotactic body radiation therapy for clinically localized prostate cancer in patients with contraindications to magnetic resonance imaging","volume":"5","author":"Paydar","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2023.100722_b0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2019.07.018","article-title":"Single fraction urethra-sparing prostate cancer SBRT: phase I results of the ONE SHOT trial","volume":"139","author":"Zilli","year":"2019","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2023.100722_b0040","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/cam4.2966","article-title":"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results","volume":"9","author":"Zilli","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ctro.2023.100722_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-023-04579-6","article-title":"State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature","author":"Le Guevelou","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.ctro.2023.100722_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109864","article-title":"Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer","volume":"188","author":"Ong","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1068","key":"10.1016\/j.ctro.2023.100722_b0055","doi-asserted-by":"crossref","first-page":"20160348","DOI":"10.1259\/bjr.20160348","article-title":"Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: an MRI based approach","volume":"89","author":"Kataria","year":"2016","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100722_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13014-019-1424-8","article-title":"The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy","volume":"14","author":"Dekura","year":"2019","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100722_b0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/mp.12830","article-title":"Changes in prostate orientation due to removal of a Foley catheter","volume":"45","author":"Litzenberg","year":"2018","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.ctro.2023.100722_b0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.radonc.2011.11.015","article-title":"Urethra sparing - potential of combined Nickel-Titanium stent and intensity modulated radiation therapy in prostate cancer","volume":"103","author":"Thomsen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100722_b0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2005.11.015","article-title":"Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy","volume":"78","author":"Carl","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100722_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2019.12.044","article-title":"Evaluating the tolerability of a simultaneous focal boost to the gross tumor in prostate SABR: a toxicity and quality-of-life comparison of two prospective trials","volume":"107","author":"Alayed","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100722_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109503","article-title":"Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - results from the 2SMART phase 2 trial","volume":"181","author":"Ong","year":"2023","journal-title":"Radiother Oncol"},{"issue":"14","key":"10.1016\/j.ctro.2023.100722_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143564","article-title":"Evaluation of T2-weighted MRI for visualization and sparing of urethra with MR-guided radiation therapy (MRgRT) on-board MRI","volume":"13","author":"Pham","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2023.100722_b0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-015-0426-4","article-title":"Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)","volume":"10","author":"Nicolae","year":"2015","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2023.100722_b0100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1109\/TMI.2004.828354","article-title":"Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation","volume":"23","author":"Warfield","year":"2004","journal-title":"IEEE Trans Med Imaging"},{"issue":"2","key":"10.1016\/j.ctro.2023.100722_b0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1076-6332(03)00671-8","article-title":"Statistical validation of image segmentation quality based on a spatial overlap index","volume":"11","author":"Zou","year":"2004","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100722_b0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jmrs.485","article-title":"Visualising the urethra for prostate radiotherapy planning","volume":"68","author":"Richardson","year":"2021","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.ctro.2023.100722_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2021.03.002","article-title":"Visualizing the urethra by magnetic resonance imaging without usage of a catheter for radiotherapy of prostate cancer","volume":"18","author":"Yoshimura","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100722_b0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0360-3016(93)90352-V","article-title":"The role of the urethrogram during simulation for localized prostate cancer","volume":"25","author":"Roach","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100722_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13014-023-02209-4","article-title":"Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience","volume":"18","author":"Moore-Palhares","year":"2023","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100722_b0130","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.prro.2022.09.007","article-title":"Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy","volume":"13","author":"Teunissen","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2023.100722_b0135","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1088\/1361-6560\/62\/8\/3003","article-title":"MRI micturating urethrography for improved urethral delineation in prostate radiotherapy planning: a case study","volume":"62","author":"Rai","year":"2017","journal-title":"Phys Med Biol"},{"issue":"7","key":"10.1016\/j.ctro.2023.100722_b0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clon.2010.05.006","article-title":"Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods","volume":"22","author":"Hanna","year":"2010","journal-title":"Clin Oncol (r Coll Radiol)"},{"key":"10.1016\/j.ctro.2023.100722_b0145","article-title":"Development of prostate bed delineation consensus guidelines for MRI-guided radiotherapy and assessment of its impact on interobserver variability","author":"Sritharan","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100722_b0150","article-title":"Consensus Delineation Guidelines for Pelvic Lymph Node Radiotherapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (Gfru)","author":"Hertogh","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:41:38Z","timestamp":1742179298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"alternative-id":["S2405630823001477"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100722","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100722"}}